CytoPrevent is a group of scientific experts from several (mostly European) countries, dedicated to increase protection for healthcare workers handling, preparing, or administering cytotoxic drugs.
This multidisciplinary initiative was launched on April 24, 2020 to raise awareness among European policymakers and recommend new measures to prevent contamination risks or make them “as low as reasonably achievable”. The CytoPrevent group involves scientists, pharmacists, doctors, nurses, who express their common views through open and independent discussions.
They want to contribute positively to current discussions around the amendment of the Directive 2004/37/EC5 2004 (Carcinogens and Mutagens Directive, CMD) and its transposition into Member States’ legislations by 11 July 2021. These experts consider very important to bring any possible light to this debate, for the purpose of providing all healthcare workers in Europe with a safe environment, especially regarding exposure to cytotoxic.